Skip to main content
Market intelligence
ABTHealthcare

Abbott Laboratories insider activity

In the last 90 days, 3 corporate insiders purchased $1,301,477 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$1,301,477
Corporate buyers
3
Latest transaction
May 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 7, 2026John G StrattonDirectorOpen Market Purchase2,000$86.82$173,640
Apr 27, 2026Daniel J StarksDirectorOpen Market Purchase10,000$92.65$926,537
Apr 23, 2026Philip P BoudreauEVP AND CFOOpen Market Purchase2,200$91.50$201,300